A potential modality for interstitial cystitis: Intravesical use of anti-inflammatory peptide RDP58

Journal of Urology

Volumn 173, Issue 2, 2005, Pages 340-

  Luo, Yi ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BCG VACCINE; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; DIMETHYL SULFOXIDE; HEPARIN; HYALURONIC ACID;

DRUG EFFECT; EDITORIAL; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION; NONHUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE;

EID: 12544249626     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000151249.65348.ca     Document Type: Editorial

References (12)

1. Overcoming Bladder Disease: National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health Pub. No. KU-185, p 103, 2002
2. Michael, Y. L., Kawachi, I., Stampfer, M. J., Colditz, G. A. and Curhan, G. C.: Quality of life among women with interstitial cystitis. J Urol, 164: 423, 2000
3. Rothrock, N. E., Lutgendorf, S. K., Hoffman, A. and Kreder, K. J.: Depressive symptoms and quality of life in patients with interstitial cystitis. J Urol, 167: 1763, 2002
4. Rothrock, N. E., Lutgendorf, S. K. and Kreder, K. J.: Coping strategies in patients with interstitial cystitis: relationships with quality of life and depression. J Urol, 169: 233, 2003
5. Selo-Ojeme, D. O. and Onwude, J. L.: Interstitial cystitis. J Obstet Gynaecol, 24: 216, 2004
6. Newsome, G.: Interstitial cystitis. J Am Acad Nurse Pract, 15: 64, 2003
7. Peters, K. M., Diokno, A. C. and Steinert, B. W.: Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder? Urology, 54: 450, 1999
8. Peters, K. M., Diokno, A. C., Steinert, B. W. and Gonzalez, J. A.: The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup. J Urol, 159: 1483, 1998
9. Bourreille, A., Doubremelle, M., de la Bletiere, D. R., Segain, J. P., Toquet, C., Buelow, R. et al: RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scand J Gastroenterol, 38: 526, 2003
10. Murthy, S., Flanigan, A., Coppola, D. and Buelow, R.: RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis. Inflamm Res, 51: 522, 2002
11. Zhao, J., Huang, L., Belmar, N., Buelow, R. and Fong, T.: Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity. Clin Cancer Res, 10: 2851, 2004
12. DeVry, C. G., Valdez, M., Gao, L., Wang, J., Kotsch, K., Volk, H. D. et al: RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis. J Neuroimmunol, 152: 33, 2004